Diabetes is one of the most prevalent, costly, and burdensome diseases in the world, affecting 382 million people worldwide in 2013. What does the typical demographic patient profile look like? And how has treatment changed over the past few years? We summarize the findings from a recently released white paper from Kantar Health on Diabetes Trends in the U.S.: Results from the National Health and Wellness Survey.
Using data derived from Kantar Health’s National Health and Wellness Survey (NHWS), the largest global self-reported general population survey in the healthcare industry, the demographic characteristics and treatment patterns of type 2 diabetes (T2D) patients were examined to derive insights into this critically important disease state.
The NHWS results found that the overall prevalence of diagnosed T2D was 10% (~22.6 million adults), with an additional 9.6% at risk (defined as having been told by a physician that they are at risk for developing diabetes, have high blood sugar, or have signs of early diabetes). Comparisons of this figure with other established sources such as the American Diabetes Association are available in the white paper here.
The annual survey found that more patients are being treated with medication (up 2%), and insulin use is more common (up 6%) (Figure 1).
FIGURE 1: TREATMENT RATES OF U.S. ADULTS WITH TYPE 2 DIABETES (2006 – 2013)
Lack of awareness of HbA1c is associated with poorer mental health and higher work absenteeism, activity impairment, and hospitalizations.
How can patients be more involved in their care? This white paper provides insights into patients’ knowledge of glycated hemoglobin levels (HbA1c), with substantial improvement over the past several years. NHWS found that 56% of patients were aware of their HbA1c levels, up twofold from 2006. The white paper further details how HbA1c level knowledge varies by other demographic factors such as race, with Hispanics making the most gains in knowledge.
As diabetes prevalence is projected to grow in the coming years, the medical and societal cost burdens are expected to increase. NHWS provides critical insight into annual trends in disease prevalence, patient demographics, knowledge of diabetes, and opportunities for improving health outcomes and reducing societal cost burden of diabetes. For deeper insight into Diabetes Trends in the U.S., download the white paper.
Companies are striving to advance beyond the buzzword of Big Data to delivering real, actionable results that change the way our healthcare system works. The power to access and analyze these enormous data sets, and then develop insights that can be acted upon at the patient, provider and policy level, can greatly improve our ability to both anticipate and treat illness. Consistent with a global effort to improve healthcare value, Big Data can also help key stakeholders better understand the effectiveness and safety of interventions. Treatment decisions, including the inputs into those decisions as well as the outputs (or the outcomes) can be more quickly and accurately assessed – in nearly real-time. Who, in the healthcare industry, is poised to do this? And what have we learned so far, using and interpreting healthcare big data, that can help us in the future?
HealthCore, a health services research organization, has been a leader in translating large data sets into real-world insight for two decades. As a wholly-owned outcomes research subsidiary of Anthem, Inc., one of the nation’s leading health benefits companies, HealthCore will showcase their Big Data innovations with case studies and actual research examples, in an upcoming Virtual Conference on Wednesday, February 18, 2015, Actionable Insights into Health Policy, Practice and Outcomes Through Research and Big Data – with a Spotlight on Oncology, from 9:30am-11:30am ET with an encore presentation from 11:30am-1:30pm ET.
How are large integrated healthcare datasets being used to make a difference in patient outcomes, medical practice, and health policy? Attend this two-hour event to find out. Just click on the Register link below.
This event will take place in the interactive virtual environment of HE-Xpo®, and attendees will be able to view real-time presentations by seven senior executives of HealthCore, ask questions, visit a virtual Exhibit Booth, download educational materials from the Learning Center, and interact with presenters and other attendees in the virtual Lounge. The meeting is free to attend; you may view the Agenda here and register here. You will need a working internet connection to take part in this virtual conference. Below is a preview of what will be presented.
“There’s lots of Big Data out there with not a lot of robust insight,” says Marcus Wilson, PharmD, President, HealthCore. “There is a limit to what you can get from it without it being effectively integrated.”
Dr. Wilson will share his views on the industry’s future in terms of research collaborations and the promise of a unique integrated research environment and health care data analytics.
“We’re looking at practical approaches to accelerate the speed at which we can develop evidence in the general population, as well as specific populations, so that we can get this information in the hands of clinicians and benefit patients earlier,” said Mark Cziraky, PharmD, Vice President of Research at HealthCore.
There is increasing interest among the pharmaceutical industry and the payer community in developing unique partnerships that reflect collaboration, connectivity, and shared decision-making among major stakeholders. HealthCore has been an active participant in multiple collaborations with various pharmaceutical companies and payers focusing on the use of real-world evidence, with an aim to cut down on the typical 17-year time frame for research evidence to reach clinical practice. Mark Cziraky will speak at this virtual event on “Evolving Research Connectivity, Better Decisions for the Health Care Industry.” Dr. Cziraky will provide examples of the processes and desired goals of various real-world evidence research collaborations, and dive into some of the implications of the research that can be conducted when stakeholders connect towards the goal of improving health outcomes for patients. If you are part of an organization interested in forming alliances with stakeholders on real-world evidence collaboratives, you will not want to miss this presentation.
“HealthCore’s environment, with its data environment and experienced researchers, provides a unique opportunity for conducting research” said Vince Willey, PharmD, Staff Vice President of HealthCore’s Industry Sponsored Research Unit. “It has the ability to pull in data from medical and pharmacy claims, clinical information from the physician, medical charts, and other information from patients that allow us to answer complex clinical, economic and health policy questions.”
Oncology therapeutics is one of the fastest growing arenas in healthcare, with cancer treatments estimated to exceed the $100 billion mark worldwide within the next few years. The promise of targeted cancer treatments, as well as the recent US and European focus on the cost-effectiveness of cancer treatments, have piqued interest in how data analytics can be used to maximize outcomes. Dr. Willey will present “A Focus on Oncology within HealthCore’s Research Environment.” He will describe the types of oncology data that are available, showcase insights derived from oncology data, and address the realized value to the healthcare industry. If you would like to better understand how data assets can be used to answer complex clinical and economic health outcomes questions in oncology, this session will be of utmost interest.
The promise of using healthcare big data to monitor safety is never far from the thoughts of many who believe that fundamental improvements in our healthcare system are on the next horizon. Crystal Holick, ScD is well-suited to delve into this topic, bringing experienced perspectives from her role as Senior Director, Safety and Epidemiology Research at HealthCore. Dr. Holick will provide an overview of how HealthCore’s research environment is used for greater insights into safety, and explore how these results were used by the pharmaceutical industry, payer audiences, and other stakeholders to improve care delivery, identify research opportunities, and advance patient outcomes. This presentation is also an important opportunity to learn more about how using databases for medical product safety assessment requires careful research consideration to ensure that the interpretation is both valid and based on rigorous analytic methods.
In the past several years, HealthCore’s collaborative approaches have extended into new health care industry arenas, including government and academic groups, thereby marshaling expertise and sharing insights to improve health policy and practice. If you work closely with academic institutions or government agencies, be sure to listen to this enlightening presentation by Nandini Selvam, PhD, Senior Director of HealthCore’s Government and Academic Research.
Rounding out this information-packed two-hour virtual event is a joint presentation by John Barron, PharmD and Andrea DeVries, PhD of HealthCore’s Payer and Provider Research division. Drs. Barron and DeVries have extensive experience managing hundreds of projects. They will provide a practical and instructive presentation on “How Research Can Provide Actionable Information to Health Plans”. Expect to hear case studies on how health plans can directly benefit from health services research to inform strategies, identify new opportunities, and gain insights into changing consumer and provider behavior.
Do you have some areas that you would like to see addressed? Some questions you would like to raise? Click on the Comment link below and share your views with HealthCore in advance.
Please do not miss this opportunity to attend the event on Wednesday, February 18, 2015, Actionable Insights into Health Policy, Practice and Outcomes Through Research and Big Data – with a Spotlight on Oncology, from 9:30am-11:30am ET with an encore presentation from 11:30am-1:30pm ET. Speakers will be available to answer your questions in real-time at the end of the 2-hour session.
If you have a conflict with this event on February 18th, you have the option to view the full presentation “on-demand” at any time. Register on the link below to receive instructions for “on-demand” access.